Literature DB >> 17123517

Visfatin is present in bovine mammary epithelial cells, lactating mammary gland and milk, and its expression is regulated by cAMP pathway.

Tomo Yonezawa1, Satoshi Haga, Yosuke Kobayashi, Tatsuyuki Takahashi, Yoshiaki Obara.   

Abstract

Visfatin was originally identified as a growth factor for immature B cells, and recently demonstrated to bind insulin receptor. Visfatin mRNA and protein were detected by RT-PCR and Western blot analysis in cloned bovine mammary epithelial cells, lactating bovine mammary gland and human breast cancer cell line, MCF-7. Immunocytochemical staining localized the visfatin protein in the cytosol and nucleus of both cells. Quantitative-RT-PCR analysis revealed that the expression of the visfatin mRNA was significantly elevated when treated with forskolin (500 microM), isopreterenol (1-10 microM) and dibutyric cyclic AMP (1 mM) for 24 h, and significantly reduced when treated with insulin (5-50 ng/ml) and dexsamethasone (0.5-250 nM) for 24 h. These results indicate that mammary epithelial cells express the visfatin protein and secrete them into the milk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123517     DOI: 10.1016/j.febslet.2006.11.014

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  An NAD(+) biosynthetic pathway enzyme functions cell non-autonomously in C. elegans development.

Authors:  Matt Crook; Melanie R Mcreynolds; Wenqing Wang; Wendy Hanna-Rose
Journal:  Dev Dyn       Date:  2014-05-10       Impact factor: 3.780

2.  Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo.

Authors:  Deepak Nagrath; Hongzhi Xu; Yoko Tanimura; Rongjun Zuo; François Berthiaume; Marco Avila; Rubin Yarmush; Martin L Yarmush
Journal:  Metab Eng       Date:  2009-06-07       Impact factor: 9.783

3.  Evaluation of irisin and visfatin levels in very low birth weight preterm newborns compared to full term newborns-A prospective cohort study.

Authors:  Nina Mól; Magdalena Zasada; Przemysław Tomasik; Katarzyna Klimasz; Przemko Kwinta
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

4.  Visfatin as a predictor for growth of fetus and infant.

Authors:  Ashraf Saber Mashhad Taraqi; Najmeh Tehranian; Shiva Pourali Roudbaneh; Matin Sadat Esmaeilzadeh; Anoshirvan Kazemnejad; Marzieh Faghani Aghoozi; Somayeh Yousefi
Journal:  Turk J Obstet Gynecol       Date:  2018-06-21

5.  Expression and regulation of nampt in human islets.

Authors:  Karen Kover; Pei Ying Tong; Dara Watkins; Mark Clements; Lisa Stehno-Bittel; Lesya Novikova; Doug Bittel; Nataliya Kibiryeva; Jacob Stuhlsatz; Yun Yan; Shui Qing Ye; Wayne V Moore
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

6.  Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.

Authors:  Sin-Hua Moi; Yi-Chen Lee; Li-Yeh Chuang; Shyng-Shiou F Yuan; Fu Ou-Yang; Ming-Feng Hou; Cheng-Hong Yang; Hsueh-Wei Chang
Journal:  Cancer Cell Int       Date:  2018-02-09       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.